Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2025 of 3546 entries
View as:

Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population

Phase: N/A Priority: Normal
NCT ID: NCT01328964 Org: User:
Start: 06/30/09 End: 05/31/10 Due: 05/31/11

Patient Characteristics and Treatment Modalities in COPD Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT03161587 Org: User:
Start: 05/31/17 End: 12/31/18 Due: 12/31/19

Provoked Craving Relief Study by NRT

Phase: N/A Priority: Normal
NCT ID: NCT01476202 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies

Phase: N/A Priority: Normal
NCT ID: NCT01332461 Org: User:
Start: 11/30/09 End: 05/31/10 Due: 05/31/11

Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140

Phase: N/A Priority: Normal
NCT ID: NCT00123890 Org: User:
Start: 06/30/05 End: 10/31/05 Due: 10/31/06

Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01873339 Org: User:
Start: 06/19/13 End: 09/12/13 Due: 09/12/14

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Phase: N/A Priority: Normal
NCT ID: NCT00604825 Org: User:
Start: 07/17/07 End: 07/23/08 Due: 07/23/09

Phase IV Observational Study in Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01453062 Org: User:
Start: 09/30/11 End: 11/30/12 Due: 11/30/13

Bioequivalence Study of Nimesulide 100 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01745614 Org: User:
Start: 07/18/10 End: 07/26/10 Due: 07/26/11

Hemorrhage Risk Prescribed Arixtra

Phase: N/A Priority: Normal
NCT ID: NCT01064362 Org: User:
Start: 01/31/10 End: 06/30/10 Due: 06/30/11

Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.

Phase: N/A Priority: Normal
NCT ID: NCT00555061 Org: User:
Start: 09/30/07 End: 08/31/08 Due: 08/31/09

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

Phase: N/A Priority: Normal
NCT ID: NCT05630820 Org: User:
Start: 12/06/22 End: 05/08/26 Due: 05/08/27

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

Phase: N/A Priority: Normal
NCT ID: NCT02020889 Org: User:
Start: 02/05/14 End: 09/05/16 Due: 09/05/17

A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.

Phase: N/A Priority: Normal
NCT ID: NCT00989625 Org: User:
Start: 11/04/08 End: 09/10/09 Due: 09/10/10

An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT01607346 Org: User:
Start: 03/27/13 End: 11/16/16 Due: 11/16/17

Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

Phase: N/A Priority: Normal
NCT ID: NCT00693615 Org: User:
Start: 10/31/00 End: 01/31/05 Due: 01/31/06

FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00370097 Org: User:
Start: 08/30/06 End: 04/12/07 Due: 04/12/08

Study In Adults And Adolescents With Seasonal Allergic Rhinitis.

Phase: N/A Priority: Normal
NCT ID: NCT00225823 Org: User:
Start: 05/31/05 End: 08/31/05 Due: 08/31/06

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Phase: N/A Priority: Normal
NCT ID: NCT01190189 Org: User:
Start: 04/01/11 End: 11/23/17 Due: 11/23/18

Study in Allergic Adults to Support the Development of Immunological Assays

Phase: N/A Priority: Normal
NCT ID: NCT01320137 Org: User:
Start: 03/31/11 End: 05/11/11 Due: 05/11/12

Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164

Phase: N/A Priority: Normal
NCT ID: NCT00650104 Org: User:
Start: 05/31/02 End: 03/31/09 Due: 03/31/10

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00169572 Org: User:
Start: 02/28/05 End: - Due: -

A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal
NCT ID: NCT02969655 Org: User:
Start: 11/21/16 End: 07/02/18 Due: 07/02/19

Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00536497 Org: User:
Start: 09/30/07 End: - Due: -

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05613205 Org: User:
Start: 11/28/22 End: 04/02/24 Due: 04/02/25